Sarcos Technology and Robotics Corporation Meets Development Milestone for its Guardian® XT™ Robotic Avatar System
Sarcos Technology and Robotics Corporation (NASDAQ: STRC, STRCW) has successfully completed the assembly of the Beta version of its Guardian XT teleoperated robotic system by the end of 2021. The dual-armed robot features enhanced dexterity and technical improvements over the Alpha model, including advanced software and motion capture capabilities. Internal Beta testing is underway, with commercial production expected to begin by late 2022. CEO Kiva Allgood expressed optimism about the system's potential impact on various industries, improving productivity while ensuring operator safety.
- Completion of the Beta version of the Guardian XT robotic system.
- Improvements in dexterity and technical features from the Alpha model.
- Internal Beta testing currently in progress.
- Commercial production planned for late 2022.
- None.
SALT LAKE CITY, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Sarcos Technology and Robotics Corporation (“Sarcos”) (NASDAQ: STRC and STRCW) today announced that the Company successfully completed assembly of the Beta version of the Guardian® XT™ teleoperated dexterous mobile robotic avatar system at the end of 2021, as scheduled. The Guardian XT robot is an upper-body variant of the award-winning Sarcos Guardian® XO® full-body, battery-powered industrial exoskeleton.
The Guardian XT system is a dual-armed teleoperated robot designed to perform tasks with human-like dexterity while keeping the operator at a safe distance in challenging and hazardous conditions, including at height. It is platform-agnostic and modular, enabling the robot to be mounted to a variety of mobile bases. The Beta version of the Guardian XT robot incorporates several technical improvements from the Alpha robot, including additional degrees of freedom in the wrist, upgraded software, more advanced end-effectors, and enhancements to the proprietary SenSuit™ motion capture controller.
Sarcos is currently conducting internal Beta testing of the Guardian XT robotic avatar system and expects to deliver units to partners for additional testing in mid-2022. Sarcos expects to commence initial production of the first commercial units of the Guardian XT robot, which will incorporate learnings from the Beta tests, at the end of 2022.
“We are extremely pleased with the progress we’ve made in the development of our Guardian XT robotic system,” said Kiva Allgood, president and CEO, Sarcos. “We’ve made some notable improvements to the Beta version, and ultimately, we believe this robot will have a significant and positive impact on a variety of industries, enabling increased productivity while keeping the operator out of harm’s way.”
For more information on Sarcos, the Guardian XT robot, and its award-winning product portfolio, please visit www.sarcos.com.
About Sarcos Technology and Robotics Corporation
Sarcos Technology and Robotics Corporation (NASDAQ: STRC and STRCW) is a leader in industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Leveraging more than 30 years of research and development, Sarcos’ mobile robotic systems, including the Guardian® S, Guardian® GT, Guardian® XO®, and Guardian® XT™, are designed to revolutionize the future of work wherever physically demanding work is done. Sarcos is based in Salt Lake City, Utah. For more information, please visit www.sarcos.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, Sarcos’ plans to expand its product availability, Sarcos’ ability to sell its products or obtain robot-as-a-service subscriptions, competition from existing or future businesses and technologies, and expected size of Sarcos’ addressable market. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or “continue” or similar expressions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results, or performance to differ materially from those indicated by such statements. These forward-looking statements are based on Sarcos’ management’s current expectations and beliefs, as well as a number of assumptions concerning future events. However, there can be no assurance that the events, results, or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Sarcos is not under any obligation and expressly disclaims any obligation, to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.
Readers should carefully review the statements set forth in the reports which Sarcos has filed or will file from time to time with the Securities and Exchange Commission (the “SEC”). In addition to factors previously disclosed in Sarcos’ reports filed with the SEC and those identified in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: Sarcos’ ability to execute on its business strategy, address staffing shortages and supply chain disruptions, launch its products within expected timelines, develop new products and services and enhance existing products and services; ability to respond rapidly to emerging technology trends; ability to compete effectively, recruit and retain qualified personnel and manage growth and costs; and other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in documents filed from time to time with the SEC. The documents filed by Sarcos with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.
Investor Contact:
Ben Mimmack
Head of Investor Relations
(801) 419-0438
pr@sarcos.com
ir@sarcos.com
FAQ
What is the Guardian XT robot from Sarcos?
When will Sarcos start producing the Guardian XT units?
What improvements does the Beta version of the Guardian XT offer?
What are the expected next steps for Sarcos after the Beta testing?
What is the stock symbol for Sarcos Technology and Robotics Corporation?
